BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 169931)

  • 21. Pre- and postjunctional blocking effects of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics.
    Singh YN; Marshall IG; Harvey AL
    Br J Anaesth; 1982 Dec; 54(12):1295-306. PubMed ID: 6293521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual action of meperidine on the frog neuromuscular junction: a prejunctional, opiate receptor-mediated depression of transmitter release and a postjunctional, nonopiate receptor effect on the endplate.
    Durham HD; Frank GB
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):150-65. PubMed ID: 6114716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The action of cobalt ions on neuromuscular transmission in the frog.
    Weakly JN
    J Physiol; 1973 Nov; 234(3):597-612. PubMed ID: 4357999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible effect of depolarization by K-propionate on sub-miniature endplate potential to bell-miniature endplate potential ratios, on miniature endplate potential frequencies and amplitudes, and on synaptic vesicle diameters and densities in frog neuromuscular junctions.
    Florey E; Kriebel ME
    Neuroscience; 1988 Dec; 27(3):1055-72. PubMed ID: 2855260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction.
    Ribeiro JA; Sebastião AM
    J Physiol; 1987 Mar; 384():571-85. PubMed ID: 2821240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic inhibition of quantal transmitter release from the magnesium-paralysed frog sartorius muscle.
    Arenson MS
    Neuroscience; 1989; 30(3):827-36. PubMed ID: 2788830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a negative quaternary ion-sodium tetraphenylboron (TPB) on the rat phrenic nerve-diaphragm preparation.
    Guideri G; Seifter E; Seifter J
    Eur J Pharmacol; 1972 Feb; 17(2):253-8. PubMed ID: 4537254
    [No Abstract]   [Full Text] [Related]  

  • 30. The relation between tonicity and impulse-evoked transmitter release in the frog.
    Kita H; Narita K; Van der Kloot W
    J Physiol; 1982 Apr; 325():213-22. PubMed ID: 6286938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postsynaptic block of frog neuromuscular transmission by conotoxin GI.
    McManus OB; Musick JR
    J Neurosci; 1985 Jan; 5(1):110-6. PubMed ID: 2981295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of mescaline and some of its analogs on cholinergic neuromuscular transmission.
    Ghansah E; Kopsombut P; Malleque MA; Brossi A
    Neuropharmacology; 1993 Feb; 32(2):169-74. PubMed ID: 8383816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Giant miniature end-plate potentials at the untreated and emetine-treated frog neuromuscular junction.
    Alkadhi KA
    J Physiol; 1989 May; 412():475-91. PubMed ID: 2600842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small mode miniature end plate potentials are increased and evoked in fatigued preparations and in high Mg2+ saline.
    Kriebel ME
    Brain Res; 1978 Jun; 148(2):381-8. PubMed ID: 207388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitation of frog neuromuscular transmission by sodium fluoride.
    Hattori T; Maehashi H
    Br J Pharmacol; 1987 Nov; 92(3):513-9. PubMed ID: 2827823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barbiturate-induced transmitter release at a frog neuromuscular junction.
    Thomson TD; Turkanis SA
    Br J Pharmacol; 1973 May; 48(1):48-58. PubMed ID: 4353318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further comparison of the effects of physostigmine and neostigmine on frog neuromuscular transmission.
    Alderdice MT
    Clin Exp Pharmacol Physiol; 1982; 9(1):35-43. PubMed ID: 6284424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity increases quantal size at the frog neuromuscular junction.
    Van der Kloot W; Van der Kloot TE
    Experientia; 1985 Jan; 41(1):47-8. PubMed ID: 3871401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog.
    Turkanis SA; Karler R
    Neuropharmacology; 1986 Nov; 25(11):1273-8. PubMed ID: 3025765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-radiation actions on the neuromuscular transmission.
    Portela A; de Xamar Oro JR; Stewart PA; Gimeno AL; Guardado I; Brennan M; Llobera OH; Pérez JC
    Acta Physiol Lat Am; 1977; 27(4):157-76. PubMed ID: 214995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.